Roche Launches cobas Mass Spec Solution
Roche has received CE mark approval for its cobas Mass Spec solution, marking a milestone in its global launch of mass spectrometry testing.
Read MorePosted by Chris Wolski | Dec 27, 2024 | Mass Spectrometry Instruments |
Roche has received CE mark approval for its cobas Mass Spec solution, marking a milestone in its global launch of mass spectrometry testing.
Read MorePosted by Chris Wolski | Dec 12, 2024 | Dementias & Alzheimer’s |
Blood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Quality Control Programs |
The External Quality Assurance Services Specialty Immunoassay program offers a external quality assessment for 13 key immunoassay analytes.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Aug 23, 2024 | Controls |
Bio-Rad launched a new liquid specialty IA control designed to enhance lab precision and efficiency in specialty immunoassay testing.
Read More